News About: Pharm. Industry
Compensational system for dishonor damages under positive progress
By taking unfortunate occasions of Chunil's (Drug wholesaler in Yeosu) nonpayment incidence the pharmaceutical industry concurred that in one way or other a compensational system for drug wholes...
Foreign invested independent management system.
Foreign invested company build up independent management system. a favorable local environment provided them to expand investments for a bright future.
By taking opportunity of an IMF crisis many multi...
Super cut-rate pharmacy faced whole business crisis.
Super cut-rate pharmacies have faced almost on the verge of bankruptcy caused by the IMF economic crisis. About 600 super cut rate pharmacies across the nation encountered a sharp fall in sales and num...
Supply crisis of pharmaceutical raw materials and diagnostic
The supply crisis of pharmaceutical raw material and diagnostic reagents seemed to be relieved, but the industry said it too early to feel comfort.
As of the end of March the pharmaceutical raw material impor...
Sales ratio of core products declined
According to an analysis of leading listed pharmaceutical firms having fiscal year ended at Dec. 31, the 1997 the sales of core products showed 729,200 million Won, which was 36.6% of the total sales of 1,999,20...
Advertising and promotion activity extremely dwindled.
The advertising activity in pharmaceutical industry appeared in significant draw back recently as a result of long time business recession. The industry seriously worried that the ailing busi...
KPHTA, discussed import pricing stability
The Imported package drug subcommittee of the Korea Pharmaceutical Trade Association held a meeting at the conference room of Hanbul Pharm. Co. on March 31 for the following agenda:
-Guidance for the appli...
Market opening of imported drugs requested by ustr.
The USTR reported to the U.S. government on April 1 that the non-tariff trade barrier of Korea in pharmaceutical import still stood too high, describing that the imported drugs were significantly discrimi...
Chunil's dishonor struck a blow to pharmaceutical industry.
As of March 31 Chunil dishonored payment in the amount of about 30 billion Won, the exact number and detailed reasons for which have not been clarified yet. Other source said the amount would be 30 billion ...
Financing cost down vital for pharmaceutical industry.
According to a recent survey reported by Dongyang Security Research Center, a high import reliance of pharmaceutical raw materials caused increased financial cost (8.54) due to the Won/dollar exchange losses, ...
